INTRODUCTION

Insulin aspart (brand name Fiasp, Novolog, Novolog Mix, Novomix, Novorapid, Novorapid Penfill, Ryzodeg) is a recombinant, biosynthetic, fast-acting insulin analogue that is used in the treatment of hyperglycemia caused by Type 1 and Type 2 diabetes mellitus.

This plasmid is designed for expressing Insulin aspart in yeast expression system Saccharomyces cerevisiae.

PRODUCT INFORMATION

Item No.: PPBD-95
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Insulin aspart
Brand Name(s): Fiasp, Novolog, Novolog Mix, Novomix, Novorapid, Novorapid Penfill, Ryzodeg
Classification: Hormones, Insulins
Amino Acid Sequence: Identical to DB01306

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Heller S, Kurtzhals P, Verge D, Lindholm A. Insulin aspart: promising early results borne out in clinical practice. Expert Opin Pharmacother. 2002 Feb;3(2):183-95.

[2] Sciacca L, Cassarino MF, Genua M, Pandini G, Le Moli R, Squatrito S, Vigneri R. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia. 2010 Aug;53(8):1743-53.

Contact Us